The Transition from Fatty Liver to NASH Associates with SAMe Depletion in db/db Mice Fed a Methionine Choline-Deficient Diet

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Digestive Diseases and Sciences

• Publication date

  2008-02-26

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1007/s10620-007-0193-7PMID 18299981PMCID PMC3991247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methionine Deficiency and Hepatic Injury in a Dietary Steatohepatitis Model

  2008influential reference
• Role of S‐adenosyl‐L‐methionine in liver health and injury

  2007influential reference
• PGC-1β controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis

  2007cited by this paper
• Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis

  2007influential reference
• Nutrient control of phosphorylation and translocation of Foxo1 in C57BL/6 and db/db mice.

  2006cited by this paper
• Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1 s⃞ Published, JLR Papers in Press, July 8, 2006.

  2006cited by this paper
• Glutathione‐enhancing agents protect against steatohepatitis in a dietary model

  2006cited by this paper
• LIVER FAILURE AND LIVER DISEASE Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis

  2006cited by this paper
• PGC-1 coactivators: inducible regulators of energy metabolism in health and disease.

  2006cited by this paper
• PGC-1α Deficiency Causes Multi-System Energy Metabolic Derangements: Muscle Dysfunction, Abnormal Weight Control and Hepatic Steatosis

  2005cited by this paper
• Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin.

  2004influential reference
• Molecular virology of hepatitis B virus.

  2004cited by this paper
• Nonalcoholic Steatohepatitis

  2004cited by this paper
• Animal models of steatohepatitis.

  2002cited by this paper
• Animal Models of Steatosis

  2001cited by this paper
• Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation

  2001cited by this paper
• Nonalcoholic Steatohepatitis: Definition and Pathology

  2001cited by this paper
• CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis.

  2000influential reference
• Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma.

  2000cited by this paper
• Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liver.

  2000cited by this paper
• S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.

  1999cited by this paper
• Differential effect of thioacetamide on hepatic methionine adenosyltransferase expression in the rat

  1999cited by this paper
• Changes in methionine adenosyltransferase during liver regeneration in the rat.

  1998cited by this paper
• Changes in methionine adenosyltransferase during liver regeneration in the rat.

  1998cited by this paper
• S-adenosylmethionine synthesis: molecular mechanisms and clinical implications.

  1997influential reference
• Abnormal splicing of the leptin receptor in diabetic mice

  1996cited by this paper
• Changes in S‐adenosylmethionine synthetase in human liver cancer: Molecular characterization and significance

  1996cited by this paper
• Carbon tetrachloride–induced hepatic injury is associated with global DNA hypomethylation and homocysteinemia: Effect of S‐adenosylmethionine treatment

  1995influential reference
• Feeding S‐adenosyl‐l‐methionine attenuates both ethanol‐induced depletion of mitochondrial glutathione and mitochondrial dysfunction in periportal and perivenous rat hepatocytes

  1995cited by this paper
• A simple HPLC method for the determination of S-adenosylmethionine and S-adenosylhomocysteine in rat tissues: the effect of vitamin B6 deficiency on these concentrations in rat liver.

  1994cited by this paper
• Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

  1993cited by this paper
• Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-methionine: a long-term study.

  1992cited by this paper
• S‐adenosylmethionine protects against acetaminophen hepatotoxicity in two mouse models

  1992cited by this paper
• Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors

  1990cited by this paper
• S‐Adenosyl‐L‐methionine attenuates alcohol‐induced liver injury in the baboon

  1990cited by this paper
• Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease.

  1989cited by this paper
• Chemoprevention of Rat Liver Carcinogenesis by S-Adenosyl-L-methionine : A Long-Term Study 1

  1989cited by this paper
• S‐adenosyl‐L‐methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis

  1988cited by this paper
• Role of phosphatidylethanolamine methylation in the synthesis of phosphatidylcholine by hepatocytes isolated from choline‐deficient rats

  1982cited by this paper
• Protective role of S-adenosyl-L-methionine on liver injury induced by D-galactosamine in rats.

  1978cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976influential reference
• A simple method for the isolation and purification of total lipides from animal tissues.

  1957cited by this paper

• Carbon tetrachloride does not promote hepatic fibrosis in ob/ob mice via downregulation of lipocalin-2 protein

  2025cites this paper
• Vitamin D supplementation alleviates high fat diet-induced metabolic associated fatty liver disease by inhibiting ferroptosis pathway

  2024cites this paper
• EFFECT OF S-ADENOSYLMETHIONINE ON HEPATIC AND METABOLIC DISORDERS IN GUINEA PIGS WITH NONALCOHOLIC STEATOHEPATITIS

  2024cites this paper
• Models of Hepatotoxicity for the Study of Chronic Liver Disease

  2023cites this paper
• Customized liver organoids as an advanced in vitro modeling and drug discovery platform for non-alcoholic fatty liver diseases

  2023cites this paper
• A multiomics comparison of weight loss interventions shows the distinct effects of bariatric surgery and intermittent fasting on hepatic metabolism

  2022cites this paper
• S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic Agent

  2022cites this paper
• Mouse models of nonalcoholic steatohepatitis and their application to new drug development

  2022cites this paper
• Methionine cycle in nonalcoholic fatty liver disease and its potential applications.

  2022cites this paper
• Корекція функціонального стану печінки при її хронічних захворюваннях

  2021cites this paper
• Melatonin-primed ADMSCs elicit an efficacious therapeutic response in improving high-fat diet induced non-alcoholic fatty liver disease in C57BL/6J mice

  2021cites this paper
• S-Adenosylmethionine Supplementation May Reduce Cancer-Related Fatigue: A Prospective Evaluation Using the FACIT-F Questionnaire in Colon Cancer Patients Undergoing Oxaliplatin-Based Chemotherapy Regimens

  2021cites this paper
• Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research

  2020cites this paper
• Early treatment efficacy of S-adenosylmethionine in patients with intrahepatic cholestasis: A systematic review.

  2020cites this paper
• Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments

  2020cites this paper
• Anti-diabetic effect of S-adenosylmethionine and α-glycerophosphocholine in KK-Ay mice

  2019cites this paper
• Animal models of NAFLD from the pathologist's point of view.

  2019cites this paper
• The role of folate in non-alcoholic fatty liver disease

  2019cites this paper
• Fatty acids and effects on in vitro and in vivo models of liver steatosis.

  2019cites this paper
• Role of Histone Acetylation and Methylation in Obesity

  2019cites this paper
• Animal models of portal hypertension.

  2019cites this paper
• Rodent Models of Nonalcoholic Fatty Liver Disease

  2019cites this paper
• Aged garlic extract ameliorates fatty liver and insulin resistance and improves the gut microbiota profile in a mouse model of insulin resistance.

  2019cites this paper
• Hepatoprotective Effect of Kombucha Tea in Rodent Model of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis

  2019cites this paper
• Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Non-Alcoholic Steatohepatitis.

  2019cites this paper
• Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research

  2018cites this paper
• Establishment of a novel non-alcoholic fatty liver disease model using cholesterol-fed rabbits with reference to the potential role of endoplasmic reticulum stress

  2018cites this paper
• Rodent models of fatty liver diseases

  2018cites this paper
• IL-11 neutralising therapies target hepatic stellate cell-induced liver inflammation and fibrosis in NASH

  2018cites this paper
• Effects of Kamichunggantang on Lipoapoptosis and inflammation of NAFLD in db/db mice

  2017cites this paper
• Nutrient sensing and metabolic changes after methionine deprivation in primary muscle cells of turbot (Scophthalmus maximus L.).

  2017cites this paper
• Morin enhances hepatic Nrf2 expression in a liver fibrosis rat model

  2017cites this paper
• Induction of Steatohepatitis (NASH) with Insulin Resistance in Wild-type B6 Mice by a Western-type Diet Containing Soybean Oil and Cholesterol

  2017cites this paper
• Genomic studies in non-alcoholic fatty liver disease

  2017cites this paper
• Animal Models of Obesity Characterized by Non-alcoholic Fatty Liver Disease (NAFLD)

  2017cites this paper
• Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma

  2016cites this paper
• Manifestation of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis in Different Dietary Mouse Models

  2016cites this paper
• A nutritional nonalcoholic steatohepatitis minipig model.

  2016cites this paper
• Feasibility and Efficacy of S-Adenosyl-L-methionine in Patients with HBV-Related HCC with Different BCLC Stages

  2016cites this paper
• Developmental Programming of Nonalcoholic Fatty Liver Disease (NAFLD)

  2016cites this paper
• The effects of diet and exercise on liver lipid metabolism

  2016influential citation
• An Overview of Mouse Models of Nonalcoholic Steatohepatitis: From Past to Present

  2016cites this paper
• DIETARY COCOA (THEOBROMA CACAO) SUPPLEMENTATION IMPROVES OBESITY-RELATED FATTY LIVER DISEASE IN MICE

  2016cites this paper
• Nonalcoholic Steatohepatitis: A Search for Factual Animal Models

  2015cites this paper
• Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research.

  2015cites this paper
• Correction: Mouse Models of Diet-Induced Nonalcoholic Steatohepatitis Reproduce the Heterogeneity of the Human Disease

  2015cites this paper
• S-Adenosyl-L-Methionine for the Treatment of Chronic Liver Disease: A Systematic Review and Meta-Analysis

  2015cites this paper
• Mouse Models of Diet-Induced Nonalcoholic Steatohepatitis Reproduce the Heterogeneity of the Human Disease

  2015cites this paper
• Pulsed Azidohomoalanine Labeling in Mammals (PALM) Detects Changes in Liver-Specific LKB1 Knockout Mice

  2015cites this paper
• Mouse Models to Study the Effect of Natural Products on Obesity-Associated NAFLD/NASH

  2015cites this paper
• ESTUDIO DE LOS MECANISMOS PATOGÉNICOS DE LA HEPATITIS C Y SU RELACIÓN CON EL DESARROLLO DE ESTEATOSIS. EFECTO DE UN TRATAMIENTO ANTIOXIDANTE CON FLAVONOIDES

  2014cites this paper
• Animal models are reliably mimicking human diseases? A morphological study that compares animal with human NAFLD

  2014cites this paper
• Animal Models for Nonalcoholic Fatty Liver Disease

  2014cites this paper
• Fast food diet with CCl4 micro-dose induced hepatic-fibrosis –a novel animal model

  2014cites this paper
• Effects of dietary choline supplementation on growth performance and hepatic lipid transport in blunt snout bream (Megalobrama amblycephala) fed high-fat diets

  2014cites this paper
• Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis

  2013cites this paper
• In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)

  2013cites this paper
• High fat diets and pathology in the guinea pig. Atherosclerosis or liver damage?

  2013cites this paper
• Oxidative stress-mediated signaling pathways: A review

  2013cites this paper
• Non-alcoholic steatohepatitis: what can we learn from animal models?

  2012cites this paper
• Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

  2012cites this paper
• Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and toll‐like receptor activation

  2012cites this paper
• The Role of Otx2 in Bypassing Restrictions of Hindbrain Progenitor Cell Proliferation and the Mechanisms of its Dysregulation in Medulloblastoma

  2012cites this paper
• Genetically modified mouse models for the study of nonalcoholic fatty liver disease.

  2012cites this paper
• Early changes in the liver‐soluble proteome from mice fed a nonalcoholic steatohepatitis inducing diet

  2012cites this paper
• S-Adenosylmethionine-dependent Protein Methylation Is Required for Expression of Selenoprotein P and Gluconeogenic Enzymes in HepG2 Human Hepatocytes

  2012cites this paper
• S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility.

  2012cites this paper
• Antioxidant Therapy in Nonalcoholic Steatohepatitis

  2012cites this paper
• Alcoholic liver disease and exacerbation by malnutrition and infections: what animal models are currently available?

  2011cites this paper
• Genetic factors affecting progression of nonalcoholic fatty liver disease

  2011cites this paper
• Does hepatic steatosis affect drug metabolizing enzymes in the liver?

  2011cites this paper
• A human-type nonalcoholic steatohepatitis model with advanced fibrosis in rabbits.

  2010cites this paper
• Metabolomic assessment of the effect of dietary cholesterol in the progressive development of fatty liver disease.

  2010cites this paper
• The role of S-adenosylmethionine in preventing oxaliplatin-induced liver toxicity: a retrospective analysis in metastatic colorectal cancer patients treated with bevacizumab plus oxaliplatin-based regimen

  2010cites this paper
• Network Analysis of Hepatic Genes Responded to High-Fat Diet in C57BL/6J Mice: Nutrigenomics Data Mining from Recent Research Findings

  2010cites this paper
• TNFα-dependent hepatic steatosis and liver degeneration caused by mutation of zebrafish s-adenosylhomocysteine hydrolase

  2009cites this paper
• Hepatic effects of a methionine-choline-deficient diet in hepatocyte RXRalpha-null mice.

  2009cites this paper
• Recent advances in nonalcoholic fatty liver disease

  2009cites this paper
• Kupffer cell activation by ambient air particulate matter exposure may exacerbate non-alcoholic fatty liver disease

  2009cites this paper
• Commonly used animal models of non-alcoholic steatohepatitis.

  2009cites this paper